Adalta Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-245
| Closed | -$175K | – | 106 |
|
|
2024
Q4 | $175K | Hold |
245
| – | – | 0.09% | 75 |
|
|
2024
Q3 | $258K | Hold |
245
| – | – | 0.13% | 68 |
|
|
2024
Q2 | $258K | Hold |
245
| – | – | 0.14% | 67 |
|
|
2024
Q1 | $236K | Hold |
245
| – | – | 0.13% | 67 |
|
|
2023
Q4 | $215K | Hold |
245
| – | – | 0.13% | 67 |
|
|
2023
Q3 | $202K | Buy |
+245
| New | +$202K | 0.14% | 64 |
|
|
2020
Q4 | – | Sell |
-342
| Closed | -$191K | – | 83 |
|
|
2020
Q3 | $191K | Hold |
342
| – | – | 0.14% | 65 |
|
|
2020
Q2 | $213K | Buy |
+342
| New | +$213K | 0.17% | 57 |
|